Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2017
SIETES contiene 92005 citas

 
 
 1 a 20 de 330 siguiente >>
Presentar resultados
Seleccionar todas
3.Enlace a cita original Cita con resumen
Anónimo. Access to medicines—the status quo is no longer an option. Lancet 2016;388:1250. [Ref.ID 100699]
4. Cita con resumen
Anónimo. UN panel questions free market approach to R&D for medicines. DIA Daily 2016:1. [Ref.ID 100664]
5. Cita con resumen
Crow D. Poorer countries need rapid access to generic drugs, UN says. Financial Times 2016:1. [Ref.ID 100663]
6. Cita con resumen
Ghinea N, Lipworth W, Kerridge I. Propaganda or the cost of innovation? Challenging the high price of new drugs. BMJ 2016;352:i1284. [Ref.ID 100333]
8. Cita con resumen
Gray AL, Wirtz VJ, 't Hoen EFM, Reich MR, Hogerzeil HV. Essential medicines are still essential. Lancet 2015;386:1601-3. [Ref.ID 99632]
9. Cita con resumen
Anónimo. TPP negotiators agree to eight years of market exclusivity for drugmakers. DIA Daily 2015:6 de octubre. [Ref.ID 99590]
10. Cita con resumen
Anónimo. India’s rejection of sobosuvir patent could allow Hep C treatment knockoffs. DIA Daily 2015:16 de enero. [Ref.ID 98719]
11. Cita con resumen
12. Cita con resumen
O'Dowd A. Exempt NHS from free trade treaty, campaigners say. BMJ 2014;348:g2876. [Ref.ID 97963]
13. Cita con resumen
Saini SD, Vijan S, Schoenfeld P, Powell AA, Moser S, Kerr EA. Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. BMJ 2014;348:g1533. [Ref.ID 97338]
14.Tiene citas relacionadas Cita con resumen
Anónimo. India's Supreme Court allows continued low-cost generics. DIA Daily 2013:2 de abril. [Ref.ID 95132]
15.Tiene citas relacionadas
Gale EAM, Yudkin JS. Politics of affordable insulin. BMJ 2011;343:566. [Ref.ID 91471]
16.Tiene citas relacionadas
Cohen D. The prickly problem of access to insulin. BMJ 2011;343:562. [Ref.ID 91470]
17.
Kesselheim AS. Using market-exclusivity incentives to promote pharmaceutical innovation. N Engl J Med 2010;363:1855-62. [Ref.ID 89608]
18. Cita con resumen
Smith RD, Lee K, Drager N. Trade and health: an agenda for action. Lancet 2009;373:768-73. [Ref.ID 85378]
19. Cita con resumen
Smith RD, Correa C, Oh C. Trade, TRIPS, and pharmaceuticals. Lancet 2009;373:684-91. [Ref.ID 85319]
20.Tiene citas relacionadas Cita con resumen
Lee K, Sridhar D, Patel M. Bridging the divide: global governance of trade and health. BMJ 2009;373:416-22. [Ref.ID 85143]
Seleccionar todas
 
 1 a 20 de 330 siguiente >>